HOMOEOPATHIC PHARMACOPOEIA CONVENT… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Phone

6107830987

Tax Period

2025-01-01 to 2025-12-31

HOMOEOPATHIC PHARMACOPOEIA CONVENTION OF THE UNITED STATES, founded in 1981, is a small nonprofit that reported $236K in total revenue in fiscal year 2025. Revenue decreased 9% compared to the prior year. Expenses of $211K left a modest 11% surplus.

Mission

To promote the art of homeopathic healing through research and the sale of homeopathic literature on the internet.

Program Service Accomplishments

Program 1

Expenses: $168,461 Revenue: $181,943

TO PROMOTE THE ART OF HOMEOPATHIC HEALING THROUGH RESEARCH AND THE SALE OF HOMEOPATHIC LITERATURE ON THE INTERNET

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $35,188

Program Service Revenue $181,943

Investment Income $19,338

Other Revenue $0

TOTAL REVENUE $236,469

Expense Breakdown

Grants Paid $0

Salaries & Benefits $65,000

Fundraising Expenses $0

Program Expenses $168,461

Other Expenses $145,652

TOTAL EXPENSES $210,652

Year-over-Year Comparison

	2025	2024	Change
Revenue	$236,469	$260,261	-0.1%
Expenses	$210,652	$282,582	-0.3%
Net Income	$25,817	$-22,321	-2.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$65,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ERIC FOXMAN	Director	8.00	Director	$65,000	$0	$65,000
TODD A HOOVER	Secretary	4.00	Director	$0	$0	$0
JOHN P BORNEMAN	Treasurer	20.00	Officer Director	$0	$0	$0
MARK S PHILLIPS	Director	4.00	Director	$0	$0	$0
PAUL MITTMAN	Director	4.00	Director	$0	$0	$0
PETER SMITH	Director	4.00	Director	$0	$0	$0
SANDRA A CHASE	Director	4.00	Officer Director	$0	$0	$0
WILLIAM E SHEVIN	President	4.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$236,469	$210,652	$1,153,682	$25,817
2024	$260,261	$282,582	$1,127,865	$-22,321
2023	$211,545	$291,363	$1,150,186	$-79,818
2022	$174,691	$262,030	$1,230,004	$-87,339
2021	$162,591	$213,854	$1,317,343	$-51,263
2020	$198,299	$205,131	$1,368,606	$-6,832
2019	$286,498	$204,805	$1,375,438	$81,693
2018	$193,253	$198,362	$1,293,745	$-5,109

HOMOEOPATHIC PHARMACOPOEIA CONVENTION OF THE UNITED STATES